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Abstract
The central nucleus of the amygdala (CeA) is involved in the expression of fear and has been implicated in
several anxiety disorders. This structure is densely innervated by DAergic projections that impinge on amygdalar neurons expressing various dopamine (DA) receptor subtypes, including D2 receptors (D2Rs). Although various pharmacological approaches have assessed the role of D2Rs in the CeA, the actual participation of
postsynaptic D2Rs in the CeA to defensive behaviors remains unclear. Here, we investigated the distribution
of D2Rs in the CeA and their role in modifying neuronal activity and fear related behaviors in mice. First, using
the mouse reporter strain D2R-EGFP, we verified that D2Rs are present both in neurons of the CeA and in
A10 dorsocaudal (A10dc) DAergic neurons that innervate the CeA. Moreover, we showed that pharmacological
stimulation of D2Rs increases the activity of protein kinase C (PKC)d cells present in the CeA, a type of neuron previously associated with reduced defensive behaviors. Finally, using a molecular genetics approach that
discriminates postsynaptic D2Rs from presynaptic D2 autoreceptors, we demonstrated that mice carrying targeted deletions of postsynaptic D2Rs in the CeA display increased risk avoidance in exploratory tasks.
Together, our results indicate that postsynaptic D2Rs in the CeA attenuate behavioral reactions to potential
environmental threats.

Significance Statement
The central nucleus of the amygdala (CeA) is a neural hub involved in risk assessment and fear-related behaviors, and its malfunction may trigger anxiety disorders. The CeA is densely innervated by dopamine (DA)
projections that activate D1 receptors (D1Rs) and D2Rs. In this study, we sought to determine the role that
postsynaptic D2Rs in the CeA exert in defensive behaviors. We first showed that pharmacological stimulation of D2Rs increases the activity of neurons known to reduce defensive behaviors. We also showed that
mice partially lacking postsynaptic D2Rs in the CeA display increased risk avoidance in exploratory tasks.
Together, our results indicate that D2Rs in the CeA attenuate behavioral reactions to potentially aversive environmental stimuli rising new perspectives to manage anxiety disorders.
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Introduction
Risk assessment, fear, and threat avoidance are highly
conserved adaptive behaviors that are essential for fitness
and survival. In some cases, however, fear responses appear as exaggerated behavioral reactions to stimuli that
do not represent a commensurate threat, underling symptoms of pathologic conditions such as anxiety and posttraumatic disorders. Uncontrollable anxiety may also lead
to compulsive behaviors commonly observed during withdrawal from major abused drugs such as opioids, cocaine, nicotine, and ethanol (Koob, 2008).
The central nucleus of the amygdala (CeA) is a neural
hub that orchestrates innate and learned fear-related behaviors. The CeA is densely innervated by DAergic fibers
arriving mainly from A10 dorsocaudal (A10dc) neurons located in the ventral periaqueductal gray (vPAG) and dorsal raphe (DR; Hasue and Shammah-Lagnado, 2002; Li et
al., 2016). The dopamine (DA) D2 receptor gene (DRD2) is
expressed in the CeA of rodents (Scibilia et al., 1992; Kim
et al., 2017; McCullough et al., 2018a,b) and humans
(Gurevich and Joyce, 1999; Xiang et al., 2008). In mice,
DA D2 receptors (D2Rs) present in the CeA have been implicated in impulsive behaviors (Kim et al., 2018), whereas
several association human studies have linked particular
genetic polymorphisms of DRD2 with avoidance behavior
(Frank and Hutchison, 2009), social phobia (Schneier et
al., 2000), social dysfunction (Lawford et al., 2006), and
anxiety-driven alcoholism (Joe et al., 2008). Given the involvement of the CeA in defensive behaviors, and its regulation by DA, we hypothesized that D2Rs in the CeA regulate
behavioral responses to potential threats, and that ablation of
postsynaptic D2Rs in the mouse CeA would increase avoidance behaviors. Although previous studies have used local
applications of antagonists to evaluate the function of D2Rs
in the CeA (Guarraci et al., 2000; De la Mora et al., 2012; De
Bundel et al., 2016), pharmacological approaches are unable
to discriminate between the blockade of presynaptic and
postsynaptic D2Rs.
In this study, we sought to investigate the role of amygdalar D2Rs in defensive and fear related behaviors. To this
end, we first evaluated the distribution of postsynaptic and
presynaptic D2Rs in the CeA. Then, we determined the pattern of CeA neurons activated by pharmacological stimulation
of D2Rs. Finally, we used a molecular genetics approach to
partially eliminate postsynaptic D2Rs from the CeA and studied their risk assessment behaviors in approach/avoidance
conflict paradigms. Altogether, our results support the hypothesis that postsynaptic D2Rs in the CeA play an active
role in threat assessment of environmental cues.
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Materials and Methods
Mice husbandry
Mice of both sexes were housed in ventilated cages
under controlled temperature and photoperiod (12/12 h
light/dark cycle, lights on from 7 A.M. to 7 P.M.), with tap
water and laboratory chow available ad libitum, and separated by sex. For behavioral experiments and drug administration 7- to 16-week-old mice were transferred to an
experimental animal room with similar housing conditions
and allowed for at least one week of habituation before
experiments. All procedures followed the Guide for the
Care and Use of Laboratory Animals, United States Public
Health Services (2011) and in agreement with the INGEBICONICET Institutional Animal Care and Use Committee.
Drd2 / and Drd2loxP/loxP mice were generated by crossing a heterozygote male mouse carrying the original floxed
exon 2- floxed PGK-neo Drd2 allele with a B6.FVB-Tg(EIIacre)C5379Lmgd/J female (The Jackson Laboratory) and then
backcrossed for .10 generations to C57BL/6J, as previously
described in detail (Bello et al., 2011). Drd2loxP/loxP mice are
conditional mutants carrying targeted loxP sites flanking Drd2
exon 2 (Drd2tm1.1Mrub/J). Drd2loxP/loxP, Drd2 / , Dat1/IRES-Cre
(Bäckman et al., 2006), Drd2-EGFP (Gong et al., 2003), and
Ai14 (Madisen et al., 2010) mice were all bred in our facility
and maintained in a C57BL/6J background.
Stereotaxic surgeries
Mice were anesthetized with ketamine (100 mg/kg, i.p.)
and xylazine hydrochloride (10 mg/kg, i.p.). A 10-ml
Hamilton syringe connected with a 36-gauge metal needle was used to infuse lentiviral vectors using a microsyringe pump at 0.1 ml/min. Stereotaxic coordinates for the
CeA were in relation to the Bregma (Paxinos and Franklin,
2008): anterior-posterior, 1.5 mm; medial-lateral, 63.0 mm;
dorsal-ventral, 4.9 mm. Following infusion, the needle was
kept at the injection site for 5 min, and then slowly withdrawn
to half way, kept there for two more minutes and then slowly
withdrawn outside the brain. Skin was sutured, local anesthesia (lidocaine gel) was applied followed by the analgesic flunixin meglumine (5 mg/kg, s.c.). Mice were maintained on a
regulated warm pad and monitored until recovery from
anesthesia.
Mice received 0.6 ml of a solution containing 3.3  108
particles/ml directly into the CeA, bilaterally. CeADrd2KO
mice were generated by stereotaxic co-injections of LV:
GAD-Cre (1.65  108 viral particles/ml) and LV:Ub-EGFP
(1.65  108 viral particles/ml) into the CeA of Drd2loxP/loxP
mice whereas control mice received injections of LV:UbEGFP (3.3  108 particles/ml) alone. The same procedure
was performed for LV:GAD-Cre and LV:Ub-EGFP injections in wild-type mice (Drd21/1) for control experiments.
Lentiviral preparations
HEK-293T cells were grown on high glucose DMEM
(Invitrogen), supplemented with 10% (v/v) fetal bovine
serum (Natocor), 0.5 mM L-glutamine, 100 U/ml penicillin
and 100 mg/ml streptomycin. Cells at 80–85% confluence
in 100-mm plates were co-transfected with 3 mg of the
lentiviral shuttle vector (either GAD-CRE or Ub-EGFP)
eNeuro.org
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together with helper vectors encoding packaging and envelope proteins (CMVD8.9 and CMV-VSVg, 3 and 1.5 mg,
respectively), using lipofectamine (Plus reagent, Thermo
Fisher Scientific). Viral particles were harvested from the culture medium 36 h after transfection, treated with RNase-free
DNase I (Invitrogen), filtered and concentrated by ultracentrifugation at 100,000  g (Ti 90 rotor, Beckman), yielding viral
suspensions at a titer of 107 TU/ml. LV aliquots were stored
at 80°C and thawed on ice before use. LV:GAD-Cre carries
Cre recombinase coding sequences driven by the mouse
GAD67 promoter whereas LV:Ub-EGFP carries EGFP coding
sequences driven by the human ubiquitin promoter. Both
viral vectors contain a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), long terminal repeats
(LTR), RNA pack and genomic RNA packaging signals, a rev
response element (RRE), a central polypurine tract (cPPT), a
central termination sequence (CTS), a 39 end PPT (3-PPT),
and a DU3 400-bp deletion in the 39 LTR.
Tissue collection and histology
Transcardiac perfusions were performed with PBS (0.9%
NaCl, 2.7 mM KCl, 10 mM K2HPO4, and 2 mM KH2PO4, pH
7.5) followed by paraformaldehyde 4% in PBS and brains
were removed and postfixed in the same solution at 4°C for
12–16 h. Brains were sectioned at 40 mm on a vibratome
(Leica) and used immediately or stored at 20°C in a solution
containing 30% (v/v) ethylene glycol, 30% (v/v) glycerol and
PBS, until they were processed for immunofluorescence.
Immunolabeling was performed as follows: free-floating sections were rinsed three times for 10 min in PBS. For protein kinase C (PKC)d immunofluorescence an antigen-retrieval
protocol was applied: following PBS rinse, sections were incubated in citrate buffer (10 mM citric acid and 0.05% Tween
20, pH 6.0) at 95°C for 5 min and then rinsed three times for
10 min in PBS. Sections were incubated for 16 h at 4°C in primary antibody solution with normal goat serum 2% (w/v),
0.3% Triton X-100, in PBS. The following primary antibodies
were used: rabbit anti-TH (1:2000; Millipore, AB5935),
chicken anti-TH (1:1000; Abcam, AB76442), rabbit anti-CFOS (1:500, Santa Cruz Biotechnology, SC-52), mouse
anti-PKCd (1:500, BD Biosciences, 610398), and chicken
anti-EGFP (1:1000; Aves, GFP-1020). After incubation with a
primary antibody, sections were rinsed twice for 20 min in
PBS and then incubated for 2 h at room temperature with
goat or donkey Alexa Fluor 488- or Alexa Fluor 555-coupled
secondary antibody 1:1000 in 0.3% Triton X-100 in PBS.
Finally, sections were rinsed twice for 20 min in PBS and
mounted with Vectashield (Vector Labs) for confocal microscopy or glycerol 50% (v/v) in PBS for fluorescence and bright
field microscopy.
Microscopy and images analysis
Confocal images for coexpression assays and quantification were obtained using a Leica Confocal TCS-SPE
microscope. Images not used for colocalization analysis
were obtained by fluorescence microscopy. Images were
analyzed with the Fiji platform (Schindelin et al., 2012) of the
ImageJ software (Rueden et al., 2017). For c-FOS quantification, cell number was semi-automatically quantified with
March/April 2022, 9(2) ENEURO.0528-21.2022
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the tool “Analyze Particles” after manually delimitating the
region of interest. Colocalization images were obtained by
confocal microscopy and was manually quantified using the
tool “Cell Counter.”
Experimental design and statistical analyses
Drug administration and c-FOS detection
Mice of both sexes older than eight weeks were used.
All drugs were dissolved in NaCl 0.9% to reach a concentration such that the injected volume was 0.1 ml per 10 g
of body weight. Experiments evaluating cocaine and quinpirole effects were performed separately, and because of
that, they were not analyzed in the same statistical analysis. Vehicle (NaCl 0.9%), cocaine hydrochloride (20 mg/
kg; Sigma) or quinpirole (1 mg/kg; Sigma) were injected
intraperitoneally. This dose of quinpirole was selected
based on a previous report showing increased expression
of the neuronal activation marker P-rpS6 in CeA neurons
(De Bundel et al., 2016). Mice were left in their home
cages and 90 min later were perfused for tissue fixation
and histology.
The number of c-FOS immunostained cells per hemisphere and coronal section (between two and five per
mouse) was obtained. For plotting, the average number of
cells between hemispheres and sections of the same
mouse was calculated. For statistical analysis, sections
corresponding to the same mouse were treated as subsamples of the same mouse. Colocalization of c-FOS
and PKCd was analyzed with a two-way generalized linear mixed model (GLMM) with Poisson distribution or
negative binomial distribution, with Drug as betweensubjects factor with two levels (vehicle and quinpirole, or
vehicle and cocaine), Neuronal population as intrasubjects factor with two levels (PKCd 1 and PKCd –), Mouse
as random variable, and Section-hemisphere as subsamples (Section-hemisphere nested in Mouse). c-FOS
in wild-type versus Drd2KO mice was analyzed with a
two-way GLMM with negative binomial distribution, with
Drug as between-subjects factor with two levels (vehicle
and quinpirole), Genotype as between-subjects factor
with two levels (wild-type and Drd2KO), Mouse as random variable and Section-hemisphere as subsamples
(Section-hemisphere nested in Mouse). Significance was
evaluated with the likelihood-ratio test (LRT). Post hoc
Tuckey’s multiple comparisons were performed.
Behavioral tests
Drd2loxP/loxP male mice older than eight weeks were injected with a combination of LV:GAD-Cre and LV:UbEGFP (CeADrd2KO group) or LV:Ub-EGFP alone (control
group), and after two to three weeks were evaluated in a
battery of tests to evaluate avoidance behaviors [open
field (OF), dark/light box test (DLBT), and elevated plus
maze (EPM)] and fear conditioning (FC). As a control experiment, wild-type male mice older than eight weeks received identical surgeries and behavioral tests except for
the FC (LV:GAD-Cre group and LV:Ub-EGFP group). Two
littermate cohorts were used to reach sample size per
group (CeADrd2KO = 9, Ctrl = 8; GAD-Cre = 7, Ub-EGFP
= 7).
eNeuro.org
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Figure 1. Postsynaptic and presynaptic distribution of D2R-expressing neurons. A, Representative confocal microscopy of coronal sections at two anteroposterior levels of the CeA of a Drd2-EGFP mouse. Magnifications of boxed areas are shown in the left bottom corners. B, Representative histology of D2R-expressing neurons (green, left) in CeA coronal sections of Drd2-EGFP.Dat1/IRES-Cre.Ai14 triple
transgenic mice. DAergic fibers (reported by Cre-induced tdTomato, in red) and their overlap with D2R-expressing neurons is shown at
the center and right, respectively. C, D, Analysis of Drd2 expression in DAergic neurons of the PAG/DR. C, Representative confocal microscopy of TH immunofluorescence on a PAG/DR coronal section of a Drd2-EGFP mouse. Magnifications of boxed areas are shown.
D, Percentage of D2R1 and D2R– neurons from total TH1 neurons in the vPAG/DR (mean 6 SEM, n = 3 mice). CeL, CeA, lateral part;
CeM, CeA, medial part; AP, antero-posterior. Scale bars: 200 mm.

Differences in avoidance behavior were evaluated with
a multivariate ANOVA (MANOVA) including the values obtained from the OF (time in center), the DLBT (time in light,
latency to first enter to light and number of entries to
light), and the EPM [percentage of time on open arms or
normalized time on open arms (see below, EPM), and entries to open arms]. In addition, the results of the
MANOVA were confirmed with individual univariate tests
(described in the section of each test).
OF exploration test. Horizontal locomotion and exploration in a novel OF were evaluated in activity boxes (Med
Associates) for 30 min for three consecutive days. Total
distance traveled during the first 5 min of each day and
the time in the center of the arena were determined using
the software Activity Monitor (Med Associates). Time in
center was evaluated by t test. Distance was evaluated in
a two-way ANOVA with repeated measures, with group
as between-subjects factor and day as intrasubject factor
with three levels (day 1, day 2, and day 3).
EPM. We used a custom-made apparatus standing
50 cm above the floor and constructed with black acrylic.
Each arm of the maze is 5 cm wide and 30 cm long. The
closed arms have black acrylic walls, 12 cm high. Mice
March/April 2022, 9(2) ENEURO.0528-21.2022

were individually placed in the center of the maze and allowed to explore for 5 min while being videotaped. Entry
to an arm was counted when more than half of the body
of the mouse was inside the arm. Percentage of time on
open arms was calculated with the formula: 100  time on
open/(time on open 1 time on closed); percentage of entries to open was calculated with the formula: 100  entries to open/(entries to open 1 entries to closed).
Univariate differences in percentage of time spent on the
open arms were evaluated with a t test; univariate differences in percentage of entries to open arms were evaluated with Wald test in a generalized linear model (GLM)
with quasi-binomial distribution. Only for the percentage
of time spent on the open arms in Drd2loxP/loxP mice, significant effect of the cohort was detected. In addition, the
variance also differed between cohorts, causing a nonnormal distribution of the residuals. Therefore, the data
were analyzed in two different ways: first, using a twoway ANOVA with group and cohort as between-subjects’
factors with variance modeling (VarIdent function, library
“nlme”); second, dividing each value by the average of its respective cohort (independently of the group) and analyzing this normalized data with a t test. Since the
eNeuro.org
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Figure 2. D2R stimulation activates CeA PKCd neurons. A, Representative histology of PKCd (green, top) and c-FOS (red, center)
double immunofluorescence in coronal sections of the CeA of WT mice receiving vehicle, cocaine (20 mg/kg, i.p.) or quinpirole
(1 mg/kg, i.p.). Insets are magnifications of the boxed areas. B, Quantification of c-FOS activation induced by cocaine; lines connect
data from the same mouse. Two-way GLMM with negative binomial family (link: log); likelihood-ratio test: type of neuron, x2(1) =
66.1, p , 0.0001; drug, x2(1) = 15.4, p , 0.0001; drug  type of neuron, x2(1) = 3.5, p = 0.06; vehicle, n = 9; cocaine, n = 7; post hoc
Tuckey’s test shown. C, Quantification of c-FOS activation induced by quinpirole; lines connect data from the same mouse. Twoway GLMM with Poisson family (link: log); likelihood-ratio test: drug  type of neuron, x2(1) = 9.3, p = 0.03; vehicle, n = 4; quinpirole,
n = 4; post hoc Tuckey’s test shown. D, Representative double immunofluorescence for c-FOS (cyan) and TH (red) in the CeA and
(E) quantification of c-FOS expression in the CeA induced by saline (Veh) or quinpirole (Quin; 1 mg/kg, i.p.) given to wild-type (wt) or
Drd2KO (KO) mice. Two-way GLMM with negative binomial family (link: log); likelihood-ratio test: drug  genotype, x2(1) , 8.1,
p , 0.01; post hoc Tuckey’s test shown. Veh: WT, n = 5; KO, n = 3; Quin: WT, n = 5; KO, n = 3. CeL, CeA, lateral part; CeM, CeA, medial part. Scale bars: 100 mm. ***p , 0.001, **p , 0.01, n.s. p . 0.05.

normalization restored the normal distribution of the residuals, normalized data were used for the MANOVA of
Drd2loxP/loxP mice instead of the original percentage of
time spent on the open arms.
Light/dark box test. A custom-made two-chamber
shuttle box containing a dividing wall with a 4  5 cm hole
in the center that allows mice free access to both sides
was used. Each chamber is 20 (w)  26 (l)  14 cm (h) with
steel walls and floor. Mice were placed on one side of the
shuttle box that was then immediately covered with a
black acrylic ceiling. The other chamber received ambient illumination. Mice were allowed to explore the chambers for
5 min while videotaped. The time before entering into the lit
compartment (latency), the time spent on the illuminated
side, and the number of entries to the lit compartment were
determined. Entry to or exit from the lit compartment was
counted when the mouse passed more than half of its body.
Univariate differences in latency and time spent on the illuminated chamber were evaluated by t test. Univariate differences in number of entries were evaluated with Wald test in a
GLM with Poisson (Drd2loxP/loxP mice) or quasi-Poisson (wildtype mice) distribution.
March/April 2022, 9(2) ENEURO.0528-21.2022

FC. The conditioning chamber consisted in an operant
chamber 14.0 (w)  15.9 (l)  12.7 (h) cm (Med Associates)
with steel rods on the floor connected to a scrambler (Med
Associates), placed inside a closed ventilated box for sensorial isolation. Mice were introduced into the chamber and light
was turned on. After 2-min habituation, three consecutive
shocks (0.35 mA, 2-s duration) were applied with an intertrial
interval of 90 s. One minute after the third shock, light turned
off and mice were removed and returned to their home
cages. Twenty-four hours later, mice were reintroduced into
the chamber for 5 min to test contextual conditioned freezing.
Mice were videotaped during the entire training and testing
sessions. Freezing behavior was hand scored by videotape
observation and freezing or active avoidance were determined in continuous 4-s bins. Freezing behavior was presented as the percentage of freezing events over total events.
Differences in the percentage of time freezing behavior in
each stage of the training (baseline, after first shock, after
second shock and after third shock) and the testing were
evaluated by MANOVA and further validated by univariate
tests. Univariate differences in the percentage of time freezing
were evaluated by Wald test in a GLM with quasi-binomial
eNeuro.org
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Figure 3. Strategy for selective genetic ablation of D2Rs in the CeA. A, Schematic of the lentiviral vectors used to express Cre driven by
the GAD67 promoter and EGFP driven by the ubiquitin promoter. B, Schematic of lentiviral vectors bilateral injections. C, Strategy for generating CeADrd2KO and control mice. D, Experimental timeline. OF, exploratory activity in an open field; EPM, elevated plus maze; DLBT,
dark/light box test; FC, fear conditioning. Each vertical bar indicates 1 day. E, Representative histology of a coronal section showing co-injections of LV:GAD-Cre and LV:Ub-EGFP into the CeA. F, LV:GAD-Cre-induced recombination in Drd2loxP/loxP mice was verified by PCR
with primers detecting deleted (Drd2–), floxed (Drd2loxP), and wild-type (Drd21) alleles from biopsies containing the CeA or thalamus, as negative control, of CeADrd2KO (n = 4) and control (n = 4) mice. Result of a mouse per group are shown, followed by a negative control (water)
and two positive controls. G, Representative histology of a coronal brain section of a Drd2-EGFP.Ai14 double transgenic mouse receiving a
stereotaxic injection of LV:GAD-Cre into the CeA. D2R1 (green), Cre-induced tomato (red).

distribution for baseline and test stages, and by likelihoodratio test in a GLMM with quasi-binomial distribution with the
Group as between subjects’ factor and Shock as within-subject factor with three levels (shock 1, shock 2, and shock 3) in
the case of the postshocks part of the training.
Software and statistics
All data represent the mean 6 SEM and were graphed
using GraphPad Prism Software (version 5.01, 2007
GraphPad Software Inc.) and analyzed using R Studio
(version 3.2.3). Data with continuous variables were analyzed by Student’s t test, ANOVA or repeated measures
ANOVA. Normal distribution and homoscedasticity were
verified with Shapiro test, QQ-plot and Levene test (library
“car”). When appropriate, variance was modeled with
VarIdent function (library “nlme”). Discrete data were analyzed
March/April 2022, 9(2) ENEURO.0528-21.2022

with GLMs or GLMM with Poisson error structure (link:loggit).
Variables corresponding to rates of success over total trials
were analyzed using GLM with binomial error structure (link:
log). For GLM and GLMM, significances were evaluated with
“likelihood-ratio test” comparing nestled models, or Wald test
in the case of quasi-binomial models. Assumptions were
evaluated assessing the absence of patterns in Pearson’s residuals graph and calculating the dispersion parameter to assess subdispersion or overdispersion. When assumptions
were not achieved, negative-binomial or quasi-Poisson distributions instead Poisson, or quasi-binomial instead binomial,
were used. For MANOVA, univariate and multivariate normality (Royston’s test, library “MVN”) and homogeneity of covariance matrices (Box test, library “biotools”) and absence of
multivariate outliers (Mahalanobis distance) were verified.

eNeuro.org
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Figure 4. D2R ablation from the CeA increases avoidance in exploratory tasks. The result of a MANOVA including every measure is
shown at the center, right. A, Dark/light box. Left, Time spent in the lit chamber. Student’s t test, t(15) =3.4; p = 0.004. Middle,
Latency to first entry into lit chamber in a dark/light box test. Student’s t test; t(15) = 2.3; p = 0.034. Right, Number of entries into
the lit chamber in a dark/light box test. GLM with Poisson family (link: log); Wald test, z = 1.7, p = 0.092. B, EPM. Top, Percentage
of time on open arms. Only in this measure, the cohort of mice had a significant effect. Therefore, the percentage of time on open
arms was analyzed in two different ways (see the Materials and Methods, EPM). Top-left, Percentage of time in open arms, two-way
(group  cohort) ANOVA with variance modeling (“VarIdent” function, applied to cohort factor), group, F(1,13) = 8.9, p = 0.011;
Cohort, F(1,13) = 19.9, p , 0.001; group  cohort, F(1,13) = 0.16, p = 0.69. Top-right, Percentage of time in open arms normalized to
the cohort average. Student’s t test; t(15) = 2.1; p = 0.049). Bottom, Percentage of entries to open arms over total entries (open1closed).
Since statistical differences between cohorts were not detected, normalization to cohort averages was not performed. Bottom-left,
Percentage of entries to open arms over entries to open and closed arms in an EPM, with data separated according to the cohort. Twoway GLMM with quasi-binomial family (link: logit); Wald test; group, t = 0.31, p = 0.76; cohort, t = 1.86, p = 0.09; group  cohort, t = 0.1,
p 0.92. Bottom-right, Percentage of entries to open arms, with data of both cohorts pulled. GLMM with quasi-binomial family (link: logit);
Wald test, t = 0.37, p = 0.72. C, Open field, Time in center of the arena during the first 5 min of exposure. Student’s t test, t(15) = 0.35,
p = 0.73. CeADrd2KO, n = 9; Ctrl, n = 8 in all experiments. ***p , 0.001, **p , 0.01, *p , 0.05, n.s. p . 0.05.

Code accessibility
Data analysis and tables can be accessed at https://
github.com/casey-e/Casey-et-al-2021.

Results
Presynaptic and postsynaptic distribution of D2R in
the CeA
To identify neurons expressing D2Rs in the CeA, we
performed a comprehensive histologic analysis of coronal
brain slices of Drd2-EGFP BAC transgenic mice (Gong et
al., 2003). In agreement with previous reports using in situ
hybridization (Kim et al., 2017; McCullough et al., 2018a),
March/April 2022, 9(2) ENEURO.0528-21.2022

we found a wide distribution of neuronal cell bodies expressing D2Rs along the lateral division of the CeA (CeL)
and through the entire antero-posterior axis of this division (Fig. 1A). In contrast, D2R-positive cell bodies were
only sparsely detected in the medial division (CeM), and
mainly located near the boundaries of the CeL (Fig. 1A).
To analyze whether D2R-expressing neurons are innervated by DAergic terminals we crossed Drd2-EGFP mice
with mutant mice carrying a DatIRES-Cre knockin allele
(Bäckman et al., 2006) and the Cre-inducible tdTomato
reporter gene Ai14 (Madisen et al., 2010) that, together,
label DAergic neurons with red fluorescence. Using these
triple transgenic mice, we found that D2R-expressing
eNeuro.org
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the interaction between drug and cell type), being 3-fold
greater in cocaine-injected mice (Fig. 2A,B) and 6-fold
greater in quinpirole-injected mice (Fig. 2A,C), in agreement with a previous report (De Bundel et al., 2016). The
effect of quinpirole was mediated exclusively by D2Rs,
since the number of c-FOS1 nuclei was not increased
when given to Drd2 / (knockout) mice (Fig. 2D,E).
These results indicate that stimulation of D2Rs activate
PKCd 1 neurons in the CeA. Because PKCd 1 neurons in
the CeA have been shown to mediate anxiolytic effects
(Haubensak et al., 2010; Cai et al., 2014), we hypothesized that D2Rs present in this region regulate risk
assessment.
Figure 5. D2R ablation from the CeA does not affect locomotion. Daily distance traveled by CeADrd2KO and control mice
during 30-min sessions of open field exploration; two-way
ANOVA with repeated measures; group, F(1,45) = 0.001, p . 0.1;
days, F(2,45) = 76.3, p , 0.001; group  days, F(2,45) = 2, p . 0.1.
CeADrd2KO, n = 9 and Ctrl, n = 8. n.s., p . 0.05.

neurons and DAergic fibers largely overlap in the CeL (Fig.
1B), suggesting that D2Rs of the CeA are functional receptors regulated by DA. In addition, we detected a low
density of DAergic fibers in the CeM, a CeA division with
sparse D2R-expressing neurons (Fig. 1B).
Then, we investigated whether the major DAergic input
to the CeA, originating from the vPAG/DR (Hasue and
Shammah-Lagnado, 2002; Li et al., 2016), expresses
D2Rs that may function as D2 autoreceptors in the CeA.
Using Drd2-EGFP mice we found that most DAergic
vPAG/DR neurons also express the reporter transgene
driven by Drd2 (81.8 6 9.7% of total TH-immunoreactive
neurons; Fig. 1C,D), a result that supports prior data suggesting D2 autoreceptor regulation of DA release in the
CeA (Bull et al., 1991). Together, these data indicate that
D2Rs in the CeA are present both postsynaptically and
presynaptically.
D2Rs stimulate PKCd1 neurons in the CeA
The neuronal circuits of the CeA involved in the processing of fear-induced behaviors have been described in
detail (Ciocchi et al., 2010; Janak and Tye, 2015; Kim et
al., 2017). A group of CeL neurons expressing the molecular marker PKCd 1 is known to reduce the expression of
defensive behaviors by inhibiting projection neurons of
the CeM (Ciocchi et al., 2010; Haubensak et al., 2010; Tye
et al., 2011). Conversely, PKCd – neurons of the CeL facilitate the expression of fear responses by inhibiting
PKCd 1 CeL neurons (Ciocchi et al., 2010; Haubensak et
al., 2010). To study the participation of D2Rs in the CeA,
we investigated whether PKCd 1 and PKCd – neurons are
differentially activated by D2R stimulation using an immunofluorescence coexpression analysis of PKCd and the
immediate early gene c-Fos. We found that both the DA
transporter blocker cocaine (20 mg/kg, i.p.) and the D2R
agonist quinpirole (1 mg/kg, i.p.) increased the number of
c-FOS1 nuclei in the CeL. Furthermore, the increase in
c-FOS expression was significantly greater in PKCd 1
neurons than in PKCd – neurons (likelihood-ratio test for
March/April 2022, 9(2) ENEURO.0528-21.2022

Ablation of postsynaptic D2Rs in the CeA increases
avoidance in exploratory tasks
To investigate the participation of amygdalar D2Rs in
behavioral reactions involved in risk assessment we generated mice partially lacking postsynaptic D2Rs in the
CeA and tested them in several approach/avoidance conflict paradigms. The molecular strategy used to specifically ablate postsynaptic D2Rs without affecting D2
autoreceptors was based on the expression of Cre recombinase directly into the CeA of Drd2loxP/loxP mice, a
homozygous strain carrying conditional Drd2 null alleles
(Bello et al., 2011). To this end, we used a lentiviral vector
expressing the Cre recombinase under the control of the
GAD67 promoter (Tolu et al., 2010; LV:GAD-Cre; Fig. 3A,
top) together with a lentiviral vector expressing EGFP
under the control of the human ubiquitin promoter that allows later visualization of the injection site (LV:Ub-EGFP;
Fig. 3A, bottom). The use of the GAD67 promoter to drive
Cre was based on the fact that CeA neurons are
GABAergic (McDonald, 1982; Ehrlich et al., 2009). We
performed bilateral stereotaxic co-injections of LV:GADCre and LV:Ub-EGFP into the CeA of Drd2loxP/loxP mice
(from now on, CeADrd2KO mice; Fig. 3B), to excise the
essential exon 2 of Drd2 (Fig. 3C). Control Drd2loxP/loxP
mice received LV:Ub-EGFP injections only (Fig. 3C). Two
to three weeks after this procedure, mice were subjected
to a battery of approach/avoidance conflict paradigms
where their behaviors were evaluated (Fig. 3D). At the
conclusion of these tests, the injection sites were determined histologically for each mouse (Fig. 3E). Cre-induced deletion of exon 2 from the floxed Drd2 alleles was
verified by PCR using DNA extracted from the CeA (Fig.
3F). In addition, to validate the efficacy of the viral vectors
to target CeA neurons expressing D2Rs, we injected LV:
GAD-Cre into the CeA of compound Drd2-EGFP.Ai14
transgenic mice and confirmed that the injections were
limited to the CeA inducing tdTomato expression in
38 6 14% (average 6 confidence interval, n = 5 injections)
of Drd2-EGFP1 neurons at the injection site (Fig. 3G).
Noteworthy, we did not detect tdTomato1 neurons in any
of the input areas projecting to the CeA, demonstrating
that transduction of the LV was restricted to postsynaptic
neurons and was not retrogradely transported.
A MANOVA for measures of approach/avoidance conflicts demonstrated that CeADrd2KO mice are significantly different from control mice (one-way MANOVA,
eNeuro.org
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Figure 6. LV:GAD-Cre injections into the CeA of Drd21/1 mice does not alter behaviors in exploratory tasks. A, Experimental design
with viral injections. B, Experimental timeline. OF, exploratory activity in an open field; EPM, elevated plus maze; DLBT, dark/light
ox test. Each vertical bar indicates 1 day. C–E, Avoidance behavior in exploratory tasks. The result of a MANOVA including every
measure is shown in the center. C, Dark/light box. Top, Time in the lit chamber. Student’s t test, t(12) = 1.3; p = 0.22. Middle, Latency to
first entry to light chamber; Student’s t test; t(12) = 1.1, p = 0.29. Bottom, Number of entries to light chamber; GLM with quasi-Poisson
family (link: log); Wald test, z = 1.51, p = 0.16. D, EPM. Top, Percentage of time on the open arms over the time on open and closed
arms; Student’s t test; t(12) = 0.21; p = 0.83. Bottom, Percentage of entries to open arms over total. GLMM with quasi-binomial family
(link: logit); Wald test, z = 0.49, p = 0.64. E, Open field, Time in center of the arena during the first 5 min of exposure; Student’s t test,
t(12) = 1.1, p = 0.29. LV:GAD-Cre, n = 7; LV:Ub-EGFP, n = 7 in all the experiments. **p , 0.01, *p , 0.05, n.s. p . 0.05.

Pillai = 0.7, approximated F(1,15) = 3.9, p = 0.03; Fig. 4). In
agreement, using univariate analysis we found that
CeADrd2KO mice spent significantly less time than control mice in the lit compartment of the dark/light box (Fig.
4A, left), showed greater latencies to enter for the first time
into this compartment (Fig. 4A, middle), and entered fewer
times into the lit box [marginal difference (p = 0.09); Fig. 4A,
right]. Similarly, CeADrd2KO mice spent significantly less
time on the open arms of the EPM than their control siblings
March/April 2022, 9(2) ENEURO.0528-21.2022

(Fig. 4B, top-left and right), and the percentage of entries
into the open arms over the total number of arm entries followed the same trend (Fig. 4B, bottom-left and right).
Differently, the time spent in the center of the OF was similar
in CeADrd2KO and control mice (Fig. 4C).
The increased avoidance behaviors observed in
CeADrd2KO mice cannot be attributed to lower motivation
for exploring new environments or to lower locomotor activity, because LV:GAD-Cre injections did not affect the
eNeuro.org
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Figure 7. Mice lacking D2R in the CeA express unaltered fear-conditioning memory. A, Contextual FC training protocol. B, Percentage
of freezing during the first 2 min of chamber habituation during the training [pre-test, GLM with quasi-binomial family (link: log); Wald test,
z = 1.23, p = 0.23]. C, Percentage of freezing after each foot shock [training session, GLMM with quasi-binomial family (link: log); LRT
test; group  shock, X2(1) = 2.8, p = 0.24; group, X2(1) = 0.2, p = 0.65; shock, X2(1) = 21.7, p , 0.001]. D, Percentage of freezing during
re-exposition to the conditioning chamber, 24 h after the training [testing session, GLM with quasi-binomial family (link: log); Wald test,
z = 0.15, p = 0.88]. Result of MANOVA including all variables is shown. CeADrd2KO, n = 9 and Ctrl, n = 8, n.s. p . 0.05.

distance traveled in the OF during the first day (when the
arena is a novel environment) or in the second or third day
(when the arena is a known environment; Fig. 5).
To verify that the increased avoidance behaviors described in Figure 4 were caused by the selective elimination of postsynaptic D2Rs from the CeA, we administered
LV:GAD-Cre and LV:Ub-EGFP directly into the CeA of
Drd21/1 mice (wild-type mice without loxP sites flanking
exon 2; Fig. 6A) and challenged them with the same battery of behavioral tests (Fig. 6B). Drd21/1 mice receiving
LV:GAD-Cre injections did not show any behavioral difference in these tests compared with mice receiving LV:UbEGFP only (one-way MANOVA, Pillai = 0.5, approximated
F(1,12) = 1.0, p = 0.48; Fig. 6C–E), indicating that the enhanced avoidance displayed by CeADrd2KO mice was in
fact because of the elimination of postsynaptic D2Rs from
the CeA. Finally, CeADrd2KO mice did not differ from
control mice in the time spent freezing when re-exposed
to a chamber previously associated to unavoidable footshocks (one-way MANOVA, Pillai = 0.2, approximately
F(1,15) = 0.6, p = 0.67; Fig. 7A–D). Together, these results
indicate that partial ablation of postsynaptic D2R in the
CeA increases avoidance in exploratory tasks and suggest that amygdalar D2Rs control behavioral responses
to riskier environments.

Discussion
In this study, we used a conditional site-specific genetic
approach in mice and found that partial ablation of postsynaptic D2Rs in the CeA increased avoidance behaviors
March/April 2022, 9(2) ENEURO.0528-21.2022

in approach/avoidance conflict paradigms, suggesting
that DA stimulation of amygdalar D2Rs regulates behavioral reactions to potential threats present in novel environments. The enhanced avoidance behavior observed in
mice partially lacking D2Rs in the CeA was more profound
when mice were studied in the DLBT than in the EPM.
This milder, although significant, effect was likely caused
by a strong and significant Cohort effect in the time spent
on the open arms of the EPM, probably driven by variable
and undetermined environmental conditions existing at
the different moments when the two mouse cohorts were
studied. Noteworthy, a two-way ANOVA indicated significant main effects of the group and the cohort, indicating
that the effect of D2R ablation in the CeA had similar effects in both cohorts.
Although D2Rs in the CeA have been previously studied
using pharmacological compounds (Guarraci et al., 2000;
De la Mora et al., 2012; De Bundel et al., 2016), we believe
this is the first report investigating the effects on defensive
behaviors elicited by the genetic ablation of postsynaptic
D2Rs directly into the CeA. Although the lentiviral-mediated approach used in this study induced only a partial
ablation of D2Rs in the injected CeA (Fig. 3G), this limited
deletion showed to be enough to alter the behavioral reactions of potentially dangerous environments (Fig. 4),
without affecting spontaneous locomotor activity (Fig. 5)
or fear memory (Fig. 7). In contrast, previous studies
based on local applications of D2R antagonists into the
CeA had shown no changes in risk avoidance behavior,
although elicited impaired reactions to FC (Guarraci et al.,
2000) and unconditioned fear (De la Mora et al., 2012).
eNeuro.org

Research Article: New Research

Such differences may be because of the fact that pharmacological agents not only act on postsynaptic D2Rs but
also on D2 autoreceptors that control DA release (Bello et
al., 2011). Indeed, using Drd2-EGFP mice, we found that
most TH-immunoreactive neurons present in the vPAG/
DR also express Drd2 (Fig. 1C,D), a result supported by
data collected in the Allen Mouse Brain Atlas showing intense labeling of Drd2 mRNA in vPAG/DR cell bodies
(Lein et al., 2007). Furthermore, the D2R antagonist sulpiride has been shown to potentiate DA release elicited by
optogenetic activation of vPAG/DR terminals reaching the
bed nucleus of the stria terminalis (Yu et al., 2021), whereas an in vitro study demonstrated that D2 autoreceptors regulate DA release in the CeA (Bull et al., 1991). Thus, functional
evidence (Bull et al., 1991; Yu et al., 2021), together with
histologic results shown in this work and in Lein et al. (2007),
indicates that DA release in the CeA is regulated by presynaptic D2 autoreceptors. Consequently, pharmacological activation or blockade of D2Rs present in the CeL are likely to
alter DA release and affect the activity of CeA neurons expressing postsynaptic DA receptors.
In agreement with a role of D2Rs of the CeA in risk
avoidance, our pharmacological results show D2R-mediated activation of CeL PKCd 1 cells (Fig. 2), a group of
neurons that has been shown to elicit anxiolytic-like effects in approach/avoidance conflict tests (Cai et al.,
2014; Griessner et al., 2021). Considering that D2Rs are
generally Gi/o-coupled receptors that decrease neuronal
excitability (Innis and Aghajanian, 1987; Lacey et al.,
1987; Uchida et al., 2000), the excitatory effect on
PKCd 1 neurons is likely because of polysynaptic transmission, a mechanism that needs to be further clarified in
future studies. Because DA agonists were applied systemically in this study, we cannot rule out the possibility
that the D2R-mediated activation of CeL PKCd 1 cells
was indirectly driven by stimulation of D2Rs located in
other brain areas. Although specific subpopulations of
PKCd 1 neurons drive defensive behaviors (Cui et al.,
2017; Kim et al., 2018), the PKCd 1 neurons activated by
quinpirole and cocaine most likely reduce anxiety-like behaviors, as c-FOS expression in the CeA elicited by cocaine or amphetamine can be prevented by exposure to
stressful environments (Day et al., 2001, 2005, 2008), suggesting that indirect DA agonists and potential threats
drive opposite effects in CeA microcircuits. Our demonstration that partial ablation of D2Rs from the CeA increased avoidance in exploratory tasks (Fig. 4) without
impairing locomotor activity (Fig. 5), together with the
finding that D2Rs activate PKCd 1 neurons in the CeL
(Fig. 2) suggest that amygdalar D2Rs are potential therapeutic targets for anxiolytic compounds. Interestingly, the
D2/D3 agonist ropinirole has shown anxiolytic effects together with motor improvements in Parkinson’s disease patients (Rogers et al., 2000; Rektorova et al., 2008; Mavrikaki
et al., 2014). In addition, it has been recently shown that CeL
PKCd 1 neurons are necessary and sufficient for the anxiolytic effect of benzodiazepines (Griessner et al., 2021).
In summary, here, we demonstrate that removing D2Rs
in the CeA increases anxiety-like behaviors, as evidenced
by reduced exploration of riskier environments. This result
March/April 2022, 9(2) ENEURO.0528-21.2022
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is consistent with the work of De Bundel and colleagues,
in which blocking D2Rs in the CeA after a FC test leads to
fear generalization, a clinical marker of anxiety disorders
(De Bundel et al., 2016). In contrast, D1R stimulation in
the CeA facilitated fear learning (Guarraci et al., 1999;
Groessl et al., 2018) and expression (Guarraci et al.,
1999), without affecting anxiety-like behaviors (Groessl et
al., 2018). Thus, we hypothesize that DA in the CeA reduces anxiety-like behaviors via D2Rs and enhances fear
learning and memory via D1R. A similar mechanism has
been proposed for DA acting in the striatum, where DA
regulates behavioral selection by enhancing the contrast
between stronger and weaker inputs reaching striatal
neurons (for review see, Nicola et al., 2004). We propose
that in the CeA, DA strengthens the value of aversive stimuli via D1Rs (Guarraci et al., 1999; Groessl et al., 2018)
and attenuates signals from low risk or neutral stimuli via
a D2R-based mechanism, as we found here and in agreement with a previous report (De Bundel et al., 2016).
Further studies will be necessary to address the participation of other DAergic receptors in amygdalar circuits mediating responses to fearful, dangerous, and high-risk
situations.

References
Bäckman CM, Malik N, Zhang Y, Shan L, Grinberg A, Hoffer BJ,
Westphal H, Tomac AC (2006) Characterization of a mouse strain
expressing Cre recombinase from the 39 untranslated region of the
dopamine transporter locus. Genesis 44:383–390.
Bello EP, Mateo Y, Gelman DM, Noaín D, Shin JH, Low MJ, Alvarez
VA, Lovinger DM, Rubinstein M (2011) Cocaine supersensitivity
and enhanced motivation for reward in mice lacking dopamine D2
autoreceptors. Nat Neurosci 14:1033–1038.
Bull DR, Bakhtiar R, Sheehan MJ (1991) Characterization of dopamine autoreceptors in the amygdala: a fast cyclic voltammetric
study in vitro. Neurosci Lett 134:41–44.
Cai H, Haubensak W, Anthony TE, Anderson DJ (2014) Central
amygdala PKC-d 1 neurons mediate the influence of multiple anorexigenic signals. Nat Neurosci 17:1240–1211.
Ciocchi S, Herry C, Grenier F, Wolff SBE, Letzkus JJ, Vlachos I,
Ehrlich I, Sprengel R, Deisseroth K, Stadler MB, Müller C, Lüthi A
(2010) Encoding of conditioned fear in central amygdala inhibitory
circuits. Nature 468:277–282.
Cui Y, Lv G, Jin S, Peng J, Yuan J, He X, Gong H, Xu F, Xu T, Li H
(2017) A central amygdala-substantia innominata neural circuitry
encodes aversive reinforcement signals. Cell Rep 21:1770–1782.
Day HEW, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson
TE, Watson SJ, Akil H (2001) Environmental novelty differentially
affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and
amygdala. J Neurosci 21:732–740.
Day HEW, Nebel S, Sasse S, Campeau S (2005) Inhibition of the central extended amygdala by loud noise and restraint stress. Eur J
Neurosci 21:441–454.
Day HEW, Kryskow EM, Nyhuis TJ, Herlihy L, Campeau S (2008)
Conditioned fear inhibits c-fos mRNA expression in the central extended amygdala. Brain Res 1229:137–146.
De Bundel D, Zussy C, Espallergues J, Gerfen CR, Girault JA, Valjent
E (2016) Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala. Mol Psychiatry 21:1545–1553.
De la Mora MP, Gallegos-Cari A, Crespo-Ramirez M, Marcellino D,
Hansson AC, Fuxe K (2012) Distribution of dopamine D 2-like receptors in the rat amygdala and their role in the modulation of unconditioned fear and anxiety. Neuroscience 201:252–266.
eNeuro.org

Research Article: New Research
Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Lüthi A (2009)
Amygdala inhibitory circuits and the control of fear memory.
Neuron 62:757–771.
Frank MJ, Hutchison K (2009) Genetic contributions to avoidancebased decisions: striatal D2 receptor polymorphisms. Neuroscience
164:131–140.
Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra
UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, Heintz N (2003) A
gene expression atlas of the central nervous system based on
bacterial artificial chromosomes. Nature 425:917–925.
Griessner J, Pasieka M, Böhm V, Grössl F, Kaczanowska J, Pliota P,
Kargl D, Werner B, Kaouane N, Strobelt S, Kreitz S, Hess A,
Haubensak W (2021) Central amygdala circuit dynamics underlying
the benzodiazepine anxiolytic effect. Mol Psychiatry 26:534–544.
Groessl F, Munsch T, Meis S, Griessner J, Kaczanowska J, Pliota P,
Kargl D, Badurek S, Kraitsy K, Rassoulpour A, Zuber J, Lessmann
V, Haubensak W (2018) Dorsal tegmental dopamine neurons gate
associative learning of fear. Nat Neurosci 21:952–962.
Guarraci F, Frohardt RJ, Young SL, Kapp BS (1999) A functional role
for dopamine transmission in the amygdala during conditioned
fear. Ann NY Acad Sci 877:732–736.
Guarraci F, Frohardt RJ, Falls WA, Kapp BS (2000) The effects of
intra-amygdaloid infusions of a D2 dopamine receptor antagonist
on Pavlovian fear conditioning. Behav Neurosci 114:647–651.
Gurevich EV, Joyce JN (1999) Distribution of dopamine D 3 receptor
expressing neurons in the human forebrain: comparison with D 2
receptor expressing neurons. Neuropsychopharmacology 20:60–
80.
Hasue RH, Shammah-Lagnado SJ (2002) Origin of the dopaminergic
innervation of the central extended amygdala and accumbens
shell: a combined retrograde tracing and immunohistochemical
study in the rat. J Comp Neurol 454:15–33.
Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy
R, Biag J, Dong H-W, Deisseroth K, Callaway EM, Fanselow MS,
Lüthi A, Anderson DJ (2010) Genetic dissection of an amygdala
microcircuit that gates conditioned fear. Nature 468:270–276.
Innis RB, Aghajanian GK (1987) Pertussis toxin blocks autoreceptormediated inhibition of dopaminergic neurons in rat substantia
nigra. Brain Res 411:139–143.
Janak PH, Tye KM (2015) From circuits to behaviour in the amygdala.
Nature 517:284–292.
Joe K, Kim D, Lae B, Yoon S, Lee H, Kim T, Cheon Y, Gwon D, Cho
S, Won H, Namgung S, Doo H (2008) Genetic association of DRD2
polymorphisms with anxiety scores among alcohol-dependent patients. Biochem Biophys Res Commun 371:591–595.
Kim B, Yoon S, Nakajima R, Lee HJ, Lim HJ, Lee YK, Choi JS, Yoon
BJ, Augustine GJ, Baik JH (2018) Dopamine D2 receptor-mediated circuit from the central amygdala to the bed nucleus of the
stria terminalis regulates impulsive behavior. Proc Natl Acad Sci
USA 115:E10730–E10739.
Kim J, Zhang X, Muralidhar S, LeBlanc SA, Tonegawa S (2017)
Basolateral to central amygdala neural circuits for appetitive behaviors. Neuron 93:1464–1479.e5.
Koob GF (2008) A role for brain stress systems in addiction. Neuron
59:11–34.
Lacey MG, Mercuri NB, North RA (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat
substantia nigra zona compacta. J Physiol 392:397–416.
Lawford BR, Young R, Noble EP, Kann B, Ritchie T (2006) The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with
post-traumatic stress disorder. Eur Psychiatry 21:180–185.
Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe
AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen
TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta
S, Dee NR, et al. (2007) Genome-wide atlas of gene expression in
the adult mouse brain. Nature 445:168–176.

March/April 2022, 9(2) ENEURO.0528-21.2022

12 of 12

Li C, Sugam JA, Lowery-Gionta EG, McElligott ZA, McCall NM,
Lopez AJ, McKlveen JM, Pleil KE, Kash TL (2016) Mu opioid receptor
modulation of dopamine neurons in the periaqueductal gray/dorsal
raphe: a role in regulation of pain. Neuropsychopharmacology
41:2122–2132.
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Hatim A, Gu H, Ng
LL, Palmiter RD, Hawrylycz MJ, Allan R, Lein ES, Zeng H (2010) A
robust and high-throughput Cre reporting and characterization.
Nat Neurosci 13:133–140.
Mavrikaki M, Schintu N, Nomikos GG, Panagis G, Svenningsson P
(2014) Ropinirole regulates emotionality and neuronal activity
markers in the limbic forebrain. Int J Neuropsychopharmacol
17:1981–1993.
McCullough KM, Morrison FG, Hartmann J, Carlezon WA, Ressler KJ
(2018a) Quantified coexpression analysis of central amygdala subpopulations. eNeuro 5:ENEURO.0010-18.2018.
McCullough KM, Daskalakis NP, Gafford G, Morrison FG, Ressler KJ
(2018b) Cell-type-specific interrogation of CeA Drd2 neurons to
identify targets for pharmacological modulation of fear extinction.
Transl Psychiatry 8:164.
McDonald AJ (1982) Cytoarchitecture of the central amygdaloid nucleus of the rat. J Comp Neurol 208:401–418.
Nicola SM, Hopf FW, Hjelmstad GO (2004) Contrast enhancement: a
physiological effect of striatal dopamine? Cell Tissue Res 318:93–106.
Paxinos G, Franklin K (2008) The mouse brain in stereotaxic coordinates, compact. San Diego, CA: Academic Press.
Rektorova I, Balaz M, Svatova J, Zarubova K, Honig I, Dostal V,
Sedlackova S, Nestrasil I, Mastik J, Bares M, Veliskova J, Dusek L
(2008) Effects of ropinirole on nonmotor symptoms of Parkinson
disease. Clin Neuropharmacol 31:261–266.
Rogers DC, Costall B, Domeney AM, Gerrard PA, Greener M, Kelly
ME, Hagan JJ, Hunter AJ (2000) Anxiolytic profile of ropinirole in
the rat, mouse and common marmoset. Psychopharmacology
(Berl) 151:91–97.
Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena
ET, Eliceiri KW (2017) ImageJ2: ImageJ for the next generation of
scientific image data. BMC Bioinformatics 18:529.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M,
Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez
JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A
(2012) Fiji: an open-source platform for biological-image analysis.
Nat Methods 9:676–682.
Schneier FR, Liebowitz MR, Abi-dargham A, Zea-ponce Y, Lin S,
Laruelle M (2000) Low dopamine D 2 receptor binding potential in
social phobia. Am J Psychiatry 157:457–459.
Scibilia RJ, Lachowicz JE, Kilts CD (1992) Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11:146–154.
Tolu S, Avale ME, Nakatani H, Pons S, Parnaudeau S, Tronche F, Vogt
A, Monyer H, Vogel R, de Chaumont F, Olivo-Marin JC, Changeux
JP, Maskos U (2010) A versatile system for the neuronal subtype specific expression of lentiviral vectors. FASEB J 24:723–730.
Tye KM, Prakash R, Kim S-Y, Fenno LE, Grosenick L, Zarabi H,
Thompson KR, Gradinaru V, Ramakrishnan C, Deisseroth K (2011)
Amygdala circuitry mediating reversible and bidirectional control
of anxiety. Nature 471:358–362.
Uchida S, Akaike N, Nabekura J (2000) Dopamine activates inward
rectifier K1 channel in acutely dissociated rat substantia nigra
neurones. Neuropharmacology 39:191–201.
Xiang L, Szebeni K, Szebeni A, Klimek V, Stockmeier CA, Karolewicz
B, Kalbfleisch J, Ordway GA (2008) Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA
in major depression. Brain Res 1207:214–224.
Yu W, Pati D, Pina MM, Schmidt KT, Boyt KM, Hunker AC, Zweifel
LS, McElligott ZA, Kash TL (2021) Periaqueductal gray/dorsal
raphe dopamine neurons contribute to sex differences in pain-related behaviors. Neuron 109:1365–1380.

eNeuro.org

